Sort
53,477 grants matching “addiction”
NIDA Clinical Trials Network: New York Node
$730,885John P Rotrosen · New York University School Of Medicine · UG1 · FY2020 · DA
NorthStar Node of the Clinical Trials Network
$730,818Gavin Bart · Hennepin Healthcare Research Institute · UG1 · FY2019 · DA
Great Lakes & Mid-Atlantic Node (GLMN) of the NIDA CTN
$730,776Niranjan Subhash Karnik · University Of Illinois At Chicago · UG1 · FY2025 · DA
Smoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-Cigarettes
$730,760Thomas H. Brandon · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2018 · DA
Project 1: The effects of cigarette package color on smoking behavior, exposure and risk perception when using low nicotine content cigarettes
$730,680Andrew Strasser · University Of Pennsylvania · U54 · FY2021 · CA
Synergistic Mechanisms of chronic Innate Immune Activation in Microglia by Opiates and HIV Infection
$730,514Suryaram Gummuluru · Boston University Medical Campus · R01 · FY2020 · DA
The short and long-term dynamics of opioid/stimulant use: Mixed methods to inform overdose prevention and treatment related to polysubstance use
$730,458Becky Lynn Genberg · Johns Hopkins University · R01 · FY2025 · DA
Harnessing ectonucleotidases to treat chronic pain
$730,301Mark J Zylka · Univ Of North Carolina Chapel Hill · R01 · FY2012 · NS
Preclinical optimization of a gene therapy for erythromelalgia and chronic pain
$730,264Fernando Aleman Guillen · Navega Therapeutics, Inc. · U44 · FY2022 · NS
Addiction Connectome Core
$730,238Anna Zilverstand · University Of Minnesota · P30 · FY2025 · DA
The effects of exposure to violence on risk for substance abuse: neural mechanisms and community level moderators
$730,193Baldwin M Way · Ohio State University · R01 · FY2017 · DA
Intensive Models of HCV Care for Injection Drug Users
$730,134Alain Litwin · Albert Einstein College Of Medicine · R01 · FY2014 · DA
Collaborative Care for Primary Care Patients with Alcohol Use Disorders
$730,080Katharine Anthony Bradley · Kaiser Foundation Health Plan Of Washington · R01 · FY2011 · AA
(PQ7)Multi-scale Analysis of Tumor Microenvironment Heterogeneity
$730,063Dean W Felsher · Stanford University · R01 · FY2018 · CA
Enhanced Smoking Cessation for University Students
$730,026Alexander V Prokhorov · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · CA
Evaluation of Clinical Effectiveness, Cost, and Implementation Factors to Optimize Scalability of Treatment for Co-Occurring SUD and PTSD Among Teens
$730,020Carla Kmett Danielson · Medical University Of South Carolina · R01 · FY2023 · DA
Respect, Trust, and Patient Outcomes in Sickle Cell Disease
$729,985Mary Catherine Beach · Johns Hopkins University · R01 · FY2012 · HL
Squirrel Monkey Breeding and Research Resource
$729,952Christian R Abee · University Of Tx Md Anderson Can Ctr · P40 · FY2017 · OD
Changing our paths: Well-being and recovery among American Indians with opioid use disorder
$729,908Brenna Greenfield · University Of Minnesota · R33 · FY2023 · DA
Leica Stellaris 5 Confocal Microscope for Shared Resource Facility
$729,878Peter W Baas · Drexel University · S10 · FY2024 · OD
HEAL PROJECT-IHP-102
$729,864Jeanette Tombaugh · Midwest Research Institute · N01 · FY2024 · DA
BD2K product for enhancing phenotypic screens
$729,842Jennifer Fuller · Genecentrix, Inc. · R44 · FY2020 · DA
oxycodone addiction: molecular and biochemical consequences
$729,788Jean Lud Cadet · National Institute On Drug Abuse · ZIA · FY2019 · DA
Structural Basis of Signal Instigation Through Metabotropic Glutamate Receptors
$729,780Georgios Skiniotis · Stanford University · R01 · FY2019 · NS
14/24 The Healthy Brain & Child Development National Consortium
$729,757Gretchen E. Bandoli · University Of California, San Diego · U01 · FY2022 · DA